Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Matteo Casula"'
Autor:
Claudio Montalto, Andrea Raffaele Munafò, Luca Arzuffi, Matteo Casula, Alessandro Mandurino-Mirizzi, Francesco Costa, Sergio Leonardi, Luigi Oltrona Visconti, Marco Ferlini
Publikováno v:
Hellenic Journal of Cardiology, Vol 66, Iss , Pp 59-66 (2022)
The Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria aims to stratify patients undergoing percutaneous coronary intervention (PCI) and are now recommended by international guidelines to stratify bleeding risk in clinical practice. W
Externí odkaz:
https://doaj.org/article/3c9870235798459caf437c77941e285f
Autor:
Anna Laura Cremonini, Andrea Pasta, Federico Carbone, Luca Visconti, Matteo Casula, Edoardo Elia, Aldo Bonaventura, Luca Liberale, Maria Bertolotto, Nathan Artom, Silvia Minetti, Paola Contini, Daniela Verzola, Roberto Pontremoli, Francesca Viazzi, Giorgio Luciano Viviani, Stefano Bertolini, Aldo Pende, Fabrizio Montecucco, Livia Pisciotta
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Background and Aim: High lipoprotein(a) [Lp(a)] is a well-established cardiovascular (CV) risk factor, but the effect of mildly elevated Lp(a) on CV health is largely unknown. Our aim was to evaluate if Lp(a) is associated with the severity of caroti
Externí odkaz:
https://doaj.org/article/1b5685523d594be69391fc489b7d0d84
Autor:
Matteo Casula, Veronica Dusi, Saskia Camps, Jérémie Gringet, Tristan Benoit, Adriano Garonna, Roberto Rordorf
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundThe management of the cardio-respiratory motion of the target and the reduction of the uncertainties related to patient's positioning are two of the main challenges that stereotactic arrhythmia radio-ablation (STAR) has to overcome. A proto
Externí odkaz:
https://doaj.org/article/63fef17c81ea4a95917ddf9d40f60bca
Publikováno v:
International Journal of Cardiology. 377:66-72
Autor:
Federico Carbone, Edoardo Elia, Matteo Casula, Aldo Bonaventura, Maria Bertolotto, Silvia Minetti, Nathan Artom, Giovanni G. Camici, Paola Contini, Roberto Pontremoli, Francesca Viazzi, Stefano Bertolini, Aldo Pende, Livia Pisciotta, Fabrizio Montecucco, Luca Liberale
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 33:185-193
Inflammation due to the excess of nutrient intake plays an important role in the pathophysiology of metabolic syndrome (MetS). Here, the potential influence of neutrophils and their degranulation markers on MetS improvement upon dietary and behaviora
Autor:
Matteo Casula, Luigi Oltrona Visconti, Marco Ferlini, Federico Fortuni, Maurizio Ferrario, Chiara Rebuffi, Roberta Rossini, S. Mauri
Publikováno v:
European Heart Journal-Quality of Care and Clinical Outcomes. Oxford University Press ({OUP})
European Heart Journal-Quality of Care and Clinical Outcomes
European Heart Journal-Quality of Care and Clinical Outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::298877379cf8bca94de3ca435613903a
https://hdl.handle.net/1887/3279538
https://hdl.handle.net/1887/3279538
Publikováno v:
European Heart Journal Supplements : Journal of the European Society of Cardiology
Patients with atrial fibrillation (AF) and chronic renal failure (CRF) represent a growing population in epidemiological terms since both conditions increase with advancing age. The association of AF and CRF is burdened with a poor prognosis and with
Publikováno v:
Future cardiology. 18(8)
Aim: Colchicine, a microtubule-disassembling (antitubulin) agent used for centuries for the treatment of gout and autoimmune diseases, is a drug of growing interest in the cardiovascular field. While in the last decades it has become cornerstone of p
Autor:
Elisabetta TANDA, Matteo CASULA, Giovanni RUIU, Sara ZAPPADU, Genadi G. GENADIEV, Stefano CAMPARINI, Roberto SANFILIPPO
Publikováno v:
Italian Journal of Vascular and Endovascular Surgery. 29
Autor:
Francesca Fabris, Luigi Oltrona Visconti, Federico Fortuni, Marco Ferlini, Sergio Leonardi, Matteo Casula
Publikováno v:
American Journal of Cardiovascular Drugs
Background In patients with atrial fibrillation (AF) receiving percutaneous coronary intervention (PCI), current guidelines recommend against combining potent oral P2Y12 inhibitors (i.e. ticagrelor or prasugrel) with oral anticoagulant (OAC) therapy,